
2026-10-15
Bovine hydroxyapatite is a high-purity, bioactive calcium phosphate compound derived from natural bovine bone sources. Widely recognized for its exceptional biocompatibility and osteoconductive properties, it serves as a critical raw material in medical aesthetics, orthopedics, and dental applications. As a premier strategic sourcing partner, Jinan Meiyi Biotechnology Co., Ltd. supplies premium-grade bovine hydroxyapatite to global R&D laboratories and CDMOs. Our rigorous quality assurance framework ensures that every batch meets stringent regulatory standards, offering formulators a reliable, scientifically validated foundation for next-generation dermal fillers, bone grafts, and cosmetic innovations.
Bovine hydroxyapatite (BHA) is a naturally occurring mineral complex primarily composed of calcium and phosphate, with a chemical structure closely resembling human bone and tooth enamel. The general formula is Ca10(PO4)6(OH)2. Unlike synthetic variants, bovine-derived hydroxyapatite retains a porous microstructure and trace elements that can enhance biological integration.
In the context of industrial supply and formulation, BHA is valued not just for its chemical composition, but for its physical morphology. The particle size, crystallinity, and purity levels are critical parameters that determine its performance in final products. For manufacturers in the medical aesthetics sector, sourcing high-quality BHA is the first step in creating safe, effective, and long-lasting aesthetic solutions.
Sourcing high-performance raw materials requires more than just finding a supplier; it demands a partner who understands the intersection of scientific rigor and market responsiveness. Jinan Meiyi Biotechnology Co., Ltd., headquartered in Jinan, Shandong Province, operates as a specialized provider of bioactive technologies. As a subsidiary of Pacific Kangtai Scientific Instruments (Jinan) Co., Ltd., we focus exclusively on the research, development support, and commercialization of active ingredients for the cosmetics and medical aesthetics industries.
It is important to clarify our operational model: Jinan Meiyi Biotechnology does not engage in direct manufacturing. Instead, we function as a strategic sourcing and quality-assured distribution partner. We leverage a well-established global supply chain network to maintain long-term cooperative relationships with internationally recognized manufacturers. This allows us to offer clients access to technically advanced, regulatory-compliant, and scientifically validated bovine hydroxyapatite without the complexities of managing multiple upstream vendors.
Our quality assurance framework centers on supplier qualification, documentation traceability, and batch-level specification verification. Every batch of bovine hydroxyapatite in our portfolio undergoes comprehensive evaluation prior to inclusion. Selection criteria are grounded in:
Each shipment is accompanied by full technical dossiers, including Certificates of Analysis (CoA), Safety Data Sheets (SDS), and regulatory status summaries. This transparency enables our clients—ranging from R&D laboratories to aesthetic clinics—to maintain full confidence in material consistency and regulatory readiness.

The versatility of bovine hydroxyapatite makes it a cornerstone ingredient in several high-value sectors. Understanding these applications helps formulators and product developers select the appropriate grade and specification for their specific needs.
In medical aesthetics, hydroxyapatite is widely used as a volumizing agent in dermal fillers. When injected into the subdermal layer, BHA particles stimulate the body’s natural collagen production. This dual action—immediate volume restoration and long-term neocollagenesis—makes it a preferred choice for treating deep wrinkles, facial contouring, and hand rejuvenation.
Jinan Meiyi Biotechnology supports formulators by supplying BHA with precise particle size distributions optimized for suspension in carrier gels like carboxymethyl cellulose (CMC). Our team provides technical consultation on rheological properties to ensure smooth injection and optimal patient outcomes.
In orthopedics and dentistry, BHA is utilized as a bone void filler. Its porous structure allows for vascular invasion and bone cell attachment, facilitating faster healing and integration with native bone. It is commonly used in spinal fusion, dental implant surgery, and trauma repair.
For these applications, purity and sterility are paramount. Our sourced materials adhere to strict biomedical standards, ensuring that the hydroxyapatite is free from pathogens and endotoxins. We work closely with CDMOs to ensure that the raw materials meet the rigorous demands of surgical implant regulations.
Bovine hydroxyapatite is increasingly popular in premium oral care formulations. Due to its affinity for tooth enamel, it is used in toothpaste and mouthwashes to remineralize early carious lesions and reduce dentin hypersensitivity. Nano-hydroxyapatite variants, which we source through our specialized network, can penetrate microscopic tubules in the dentin, providing effective relief from sensitivity.
Selecting the right bovine hydroxyapatite requires a clear understanding of technical parameters. Different applications demand different physical and chemical characteristics. Below is a comparative overview of common specifications available through our curated portfolio.
| Parameter | Cosmetic Grade (Nano/Micro) | Medical/Implant Grade | Dental Care Grade |
|---|---|---|---|
| Particle Size | 20nm – 5μm | 100μm – 2mm (Granules) | 50nm – 100nm |
| Purity Level | > 98% | > 99.5% | > 97% |
| Crystallinity | Low to Medium | High | Medium |
| Primary Application | Skin creams, Serums | Bone grafts, Dermal Fillers | Toothpaste, Remineralization |
| Regulatory Focus | Cosmetic Safety Assessment | Biocompatibility (ISO 10993) | Oral Safety Standards |
When integrating bovine hydroxyapatite into your formulations, consider the following factors to optimize performance:

In a market flooded with generic suppliers, Jinan Meiyi Biotechnology distinguishes itself through a partnership-oriented service model. We do not simply transact; we collaborate. Our approach is rooted in four key strengths that deliver tangible value to our clients across Asia, Europe, and North America.
Our team possesses deep specialization in bioactive technology applications within cosmetics and medical aesthetics. Supported by continuous exposure to international research frontiers, we understand the nuances of ingredient functionality. We actively monitor emerging trends in dermatological research and minimally invasive aesthetics, integrating these insights into our portfolio strategy.
We enable reliable access to high-integrity, functionally validated ingredients backed by robust documentation. By partnering with certified manufacturers that adhere to internationally accepted quality management systems, we mitigate supply chain risks. Our clients benefit from consistent access to materials that are technically advanced and compliant with evolving regional regulations.
We prioritize clinically meaningful innovation and regulatory clarity over breadth or volume. Every product in our portfolio, including bovine hydroxyapatite, is selected based on rigorous assessment of clinical relevance and technological differentiation. This disciplined approach ensures that our clients receive only the most effective and market-ready solutions.
Technical consultation and regulatory intelligence sharing are integral to our client engagement. Whether you are an R&D laboratory developing a new filler formula or a clinic seeking differentiated solutions, we provide agile responsiveness to your dynamic needs. We help navigate the complex landscape of regulatory requirements, ensuring smoother product launches and market entry.
Yes, when sourced from reputable suppliers and processed to high purity standards, bovine hydroxyapatite is considered safe for injectable applications. It is biocompatible and biodegradable. However, it is crucial to ensure that the material is free from organic residues and endotoxins. Jinan Meiyi Biotechnology ensures that all medical-grade BHA supplied comes with comprehensive safety data and compliance documentation.
Synthetic hydroxyapatite is chemically identical but lacks the natural porous structure and trace elements found in bovine-derived sources. Many experts believe that the natural microstructure of bovine hydroxyapatite offers superior osteoconductivity and integration capabilities. Additionally, some formulators prefer the natural origin for marketing purposes in the “clean beauty” or “natural aesthetic” segments.
Bovine hydroxyapatite should be stored in a cool, dry place, away from direct sunlight and moisture. Maintaining strict control over storage conditions is essential to prevent clumping or contamination. Jinan Meiyi Biotechnology maintains strict protocols for shipping and storage to ensure product integrity from origin to end-user. We recommend using sealed containers and following the specific storage instructions provided in the technical dossier for each batch.
While we do not manufacture the material ourselves, our strategic partnerships with leading manufacturers allow us to source specific particle size distributions tailored to your formulation needs. Whether you require nano-particles for skincare or larger granules for bone grafting, we can facilitate the procurement of customized specifications through our verified supply chain.
Every shipment of bovine hydroxyapatite from Jinan Meiyi Biotechnology is accompanied by a full technical dossier. This typically includes a Certificate of Analysis (CoA), Safety Data Sheet (SDS), and relevant regulatory status summaries. For medical-grade materials, additional biocompatibility test reports may be available upon request, ensuring full traceability and compliance for your regulatory submissions.
Working with bioactive raw materials presents unique challenges. Being aware of these common pitfalls can help streamline your development process.
Inconsistent particle sizes can lead to uneven texture in dermal fillers or reduced efficacy in bone grafts. Solution: Partner with a supplier like Jinan Meiyi Biotechnology that enforces strict batch-level specification verification. We ensure that the particle size distribution matches the technical agreement before shipment.
Navigating the regulatory landscape for animal-derived ingredients can be complex, especially in regions with strict TSE/BSE (Transmissible Spongiform Encephalopathy/Bovine Spongiform Encephalopathy) regulations. Solution: We provide materials sourced from regions with favorable regulatory status and complete documentation regarding the origin and processing of the bovine source, helping you mitigate regulatory risks.
Reliance on single-source manufacturers can lead to disruptions. Solution: Our globally integrated supply chain network diversifies risk. By maintaining relationships with multiple certified manufacturers, we ensure continuity of supply even when individual facilities face operational challenges.
Bovine hydroxyapatite remains a gold standard in bioactive materials for medical aesthetics and healthcare. Its proven track record in biocompatibility and efficacy makes it indispensable for innovative product development. However, the quality of the final product is inherently linked to the quality of the raw material source.
Jinan Meiyi Biotechnology Co., Ltd. stands as your trusted enabler in this value chain. By combining scientific rigor with a responsive, partnership-driven service model, we simplify the sourcing process for R&D laboratories, CDMOs, and aesthetic clinics. We do not just supply materials; we provide the technical confidence and regulatory clarity needed to bring safe, effective products to market.
Ready to secure a reliable supply of high-purity bovine hydroxyapatite? Contact our technical team today to discuss your specific formulation requirements, request sample dossiers, or explore how our strategic sourcing capabilities can support your next innovation.
Explore Our Full Range of Bioactive Raw Materials and Technical Solutions